Karyopharm TherapeuticsKPTI
那斯達克 · USD
1.67
-0.05
(-2.91%)
盤中 09/10 12:11 (UTC+8)
09/10 12:11 (UTC+8)
Karyopharm TherapeuticsKPTI
1.67
-0.05
(-2.91%)
財務數據
損益表
- 0.33
- 0.43
- 0.39
- 0.31
- 0.30
- 0.38
- 0.44
- 0.34
- 0.35
- 0.33
- -1.84
- 29.16
- -9.36
- -21.25
- -1.73
- 26.37
- 16.12
- -22.63
- 2.90
- -4.66
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 33,432 | 35,066 | 34,079 | 44,044 | 37,929 | 30,015 | 30,542 | 38,783 | 42,786 | 33,126 |
營業成本 | 1,085 | 1,345 | 1,484 | 2,113 | 1,051 | 1,301 | 1,331 | 1,300 | 1,465 | 1,911 |
營業毛利 | 32,347 | 33,721 | 32,595 | 41,931 | 36,878 | 28,714 | 29,211 | 37,483 | 41,321 | 31,215 |
營業費用 | 54,873 | 60,481 | 50,439 | 57,151 | 61,265 | 61,970 | 60,492 | 63,766 | 69,441 | 64,974 |
研發費用 | 28,957 | 33,797 | 27,667 | 30,544 | 32,788 | 34,618 | 33,302 | 36,134 | 38,371 | 35,425 |
推銷及管理費用 | 25,916 | 26,684 | 22,772 | 26,607 | 28,477 | 27,352 | 27,190 | 27,632 | 31,070 | 29,549 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -22,526 | -26,760 | -17,844 | -15,220 | -24,387 | -33,256 | -31,281 | -26,283 | -28,120 | -33,759 |
其他收入及費用 | -31,353 | 16,922 | -71,802 | -6,865 | -1,597 | 20,824 | 11,596 | 5,624 | 60,928 | 2,352 |
利息費用 | 13,144 | 12,553 | 12,619 | 11,008 | 11,228 | 10,994 | 11,204 | 11,385 | 8,949 | 5,884 |
稅前純益 | -67,023 | -22,391 | -102,265 | -33,093 | -37,212 | -23,426 | -30,889 | -32,044 | 23,859 | -37,291 |
所得稅 | - | 1 | -67 | 34 | 40 | 36 | -109 | 28 | 67 | 71 |
稅後純益 | -67,023 | -22,392 | -102,198 | -33,127 | -37,252 | -23,462 | -30,780 | -32,072 | 23,792 | -37,362 |
基本每股稅後盈餘(元) | -2.32 | -1.02 | -5.71 | -3.82 | -4.32 | -2.77 | -0.24 | -0.26 | 0.15 | -0.32 |
稀釋每股稅後盈餘(元) | -2.27 | -1.24 | -7.00 | -3.82 | -4.32 | -2.77 | -0.24 | -0.21 | -0.16 | -0.32 |
基本平均股數(千股) | 28938.00 | 22014.00 | 17904.00 | 8669.00 | 8620.00 | 8470.00 | 125880.00 | 125039.00 | 121034.00 | 115499.00 |
稀釋平均股數(千股) | 28938.00 | 24715.00 | 17904.00 | 8669.00 | 8620.00 | 8470.00 | 125880.00 | 125039.00 | 154424.00 | 115499.00 |
還原基本每股稅後盈餘(元) | -2.32 | -1.02 | -5.71 | -3.82 | -4.32 | -2.77 | -3.60 | -3.85 | 2.26 | -4.85 |
還原稀釋每股稅後盈餘(元) | -2.27 | -1.24 | -7.00 | -3.82 | -4.32 | -2.77 | -3.60 | -3.15 | -2.35 | -4.85 |
還原基本平均股數(千股) | 28,938 | 22,014 | 17,904 | 8,669 | 8,620 | 8,470 | 8,392 | 8,336 | 8,069 | 7,700 |
還原稀釋平均股數(千股) | 28,938 | 24,715 | 17,904 | 8,669 | 8,620 | 8,470 | 8,392 | 8,336 | 10,295 | 7,700 |
EBITDA(千元) | -51,415 | -7,462 | -87,191 | -19,201 | -23,306 | -10,017 | -17,639 | -18,700 | 33,626 | -32,025 |